Percentage of patients where severe hypotension during anesthesia induction (defined as MAP < 55 mmHg) was avoided.
Intraoperative hypotension is associated with compromised organ perfusion and puts patients at risk for post-operative mortality, cardiac adverse events (CAEs), acute kidney injury, and stroke. Multiple studies have demonstrated the association of a decreased mean arterial pressure and postoperative morbidity and mortality.1-2 One retrospective review included 33,000 non-cardiac surgical patients and determined that a mean arterial pressure less than 55mmHg predicted CAEs and adverse renal-related outcomes.5 This was confirmed by a distinct investigation of 5,000 patients using invasive blood pressure measurement.4 Specifically around the time of induction, severe hypotension is common and at least partially treatable. One study documenting approximately 26% of older adults undergoing general anesthetic induction experience this outcome3.
Induction Start to Surgery Start.
If Surgery Start not available, Induction End.
Adult patients requiring anesthesia.
MAP > 55mmHG throughout the induction time period
For cesarean section cases, measure start is determined by the Cesarean Delivery Start Time phenotype.
Instances where there are two blood pressure monitoring methods, the higher MAP will be used to determine measure compliance. Artifact readings will be identified and removed from final measurement calculation. Artifact processing will occur according to the Blood Pressure Observations phenotype.
In the measure result details, invasive blood pressure values with MAP <55 mmHg triggering a flagged case will be labeled as ‘invasive'. Noninvasive blood pressure values with MAP < 55mmHg triggering a flagged case will be labeled as ‘noninvasive'. If the case has both noninvasive and invasive blood pressure values with MAP < 55 mmHg during the induction time period, the case will be labeled as ‘invasive'. The number of minutes of MAP<55mmHg during the induction time period will also be resulted.
*This measure will include only valid MPOG cases as defined by the Is Valid Case phenotype.
Not Applicable
Provider(s) signed in during induction.
Measure Author | Institution |
---|---|
Rob Schonberger, MD | Yale University |
Meridith Wade, MSN, RN | University of Michigan |
Nirav Shah, MD | University of Michigan |
Mark Dehring | University of Michigan |
Date Reviewed | Reviewer | Institution | Summary | QC Vote |
---|---|---|---|---|
TBD | TBD | TBD | TBD | TBD |
Date | Criteria | Revision |
---|---|---|
9/15/2022 | Measure End | Modified from Induction End to Surgery End |
7/5/2022 | Initial Publication |